25 XP   0   0   10

Theratechnologies Inc.
Buy, Hold or Sell?

Let's analyse Theratech together

PenkeI guess you are interested in Theratechnologies Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Theratechnologies Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Theratechnologies Inc.

I send you an email if I find something interesting about Theratechnologies Inc..

Quick analysis of Theratech (30 sec.)










What can you expect buying and holding a share of Theratech? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$-0.62
Expected worth in 1 year
C$-0.92
How sure are you?
27.5%

+ What do you gain per year?

Total Gains per Share
C$-0.30
Return On Investment
-16.5%

For what price can you sell your share?

Current Price per Share
C$1.81
Expected price per share
C$1.63 - C$3.29
How sure are you?
50%

1. Valuation of Theratech (5 min.)




Live pricePrice per Share (EOD)

C$1.81

Intrinsic Value Per Share

C$-4.89 - C$-3.19

Total Value Per Share

C$-5.51 - C$-3.81

2. Growth of Theratech (5 min.)




Is Theratech growing?

Current yearPrevious yearGrowGrow %
How rich?-$20.8m-$10.5m-$23.5m-69.1%

How much money is Theratech making?

Current yearPrevious yearGrowGrow %
Making money-$5.9m-$11.8m$5.8m97.2%
Net Profit Margin-31.2%-60.0%--

How much money comes from the company's main activities?

3. Financial Health of Theratech (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

What can you expect buying and holding a share of Theratech? (5 min.)

Welcome investor! Theratech's management wants to use your money to grow the business. In return you get a share of Theratech.

What can you expect buying and holding a share of Theratech?

First you should know what it really means to hold a share of Theratech. And how you can make/lose money.

Speculation

The Price per Share of Theratech is C$1.81. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Theratech.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Theratech, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$-0.62. Based on the TTM, the Book Value Change Per Share is C$-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is C$-0.15 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Theratech.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps-0.06-3.3%-0.10-5.5%-0.12-6.9%-0.08-4.7%-0.05-3.0%
Usd Book Value Change Per Share0.4525.0%-0.05-3.0%-0.11-5.9%-0.05-2.5%-0.02-1.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.4525.0%-0.05-3.0%-0.11-5.9%-0.05-2.5%-0.02-1.0%
Usd Price Per Share1.56-1.07-2.31-2.64-2.84-
Price to Earnings Ratio-6.52--5.89--5.59--15.02--1.83-
Price-to-Total Gains Ratio3.45--61.81--29.76--76.39--87.16-
Price to Book Ratio-3.44--2.05--3.98-8.01-8.23-
Price-to-Total Gains Ratio3.45--61.81--29.76--76.39--87.16-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.314784
Number of shares760
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.05-0.05
Usd Total Gains Per Share-0.05-0.05
Gains per Quarter (760 shares)-41.15-34.57
Gains per Year (760 shares)-164.61-138.27
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-165-1750-138-148
20-329-3400-277-286
30-494-5050-415-424
40-658-6700-553-562
50-823-8350-691-700
60-988-10000-830-838
70-1152-11650-968-976
80-1317-13300-1106-1114
90-1481-14950-1244-1252
100-1646-16600-1383-1390

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%7.033.00.017.5%15.093.00.013.9%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%2.018.00.010.0%11.029.00.027.5%33.075.00.030.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.0108.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%2.018.00.010.0%11.029.00.027.5%33.075.00.030.6%

Fundamentals of Theratech

About Theratechnologies Inc.

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen. Its pipeline products include F8 Formulation that is in Phase 2b/3 clinical trials for studying tesamorelin for the treatment of nonalcoholic steatohepatitis; multi -dose pen injector for the administration of tesamorelin; SORT1+ Technology Platform for the development of proprietary peptides for cancer drug development targeting SORT1 receptors; Sudocetaxel Zendusortide, which is in Phase 1 Clinical Trial for various solid tumor types, including HR+ breast, triple negative breast, ovarian, endometrial, melanoma, thyroid, small cell lung, and prostate cancers. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

Fundamental data was last updated by Penke on 2024-04-12 19:59:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Theratechnologies Inc..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Theratech earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Theratech to the Biotechnology industry mean.
  • A Net Profit Margin of -11.7% means that $-0.12 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Theratechnologies Inc.:

  • The MRQ is -11.7%. The company is making a huge loss. -2
  • The TTM is -31.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-11.7%TTM-31.2%+19.5%
TTM-31.2%YOY-60.0%+28.8%
TTM-31.2%5Y-38.2%+6.9%
5Y-38.2%10Y-2,778.2%+2,740.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.7%-199.6%+187.9%
TTM-31.2%-213.0%+181.8%
YOY-60.0%-279.3%+219.3%
5Y-38.2%-438.4%+400.2%
10Y-2,778.2%-605.5%-2,172.7%
1.1.2. Return on Assets

Shows how efficient Theratech is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Theratech to the Biotechnology industry mean.
  • -3.5% Return on Assets means that Theratech generated $-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Theratechnologies Inc.:

  • The MRQ is -3.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.5%TTM-8.2%+4.6%
TTM-8.2%YOY-12.1%+4.0%
TTM-8.2%5Y-6.9%-1.2%
5Y-6.9%10Y-5.1%-1.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.5%-13.5%+10.0%
TTM-8.2%-12.9%+4.7%
YOY-12.1%-11.8%-0.3%
5Y-6.9%-14.1%+7.2%
10Y-5.1%-16.0%+10.9%
1.1.3. Return on Equity

Shows how efficient Theratech is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Theratech to the Biotechnology industry mean.
  • 0.0% Return on Equity means Theratech generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Theratechnologies Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-22.2%+22.2%
TTM-5Y-28.5%+28.5%
5Y-28.5%10Y-17.9%-10.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.9%+16.9%
TTM--16.1%+16.1%
YOY-22.2%-15.1%-7.1%
5Y-28.5%-19.9%-8.6%
10Y-17.9%-20.9%+3.0%

1.2. Operating Efficiency of Theratechnologies Inc..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Theratech is operating .

  • Measures how much profit Theratech makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Theratech to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Theratechnologies Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-17.2%+17.2%
TTM-17.2%YOY-50.9%+33.7%
TTM-17.2%5Y-28.7%+11.5%
5Y-28.7%10Y-2,447.8%+2,419.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--295.1%+295.1%
TTM-17.2%-225.8%+208.6%
YOY-50.9%-288.4%+237.5%
5Y-28.7%-477.4%+448.7%
10Y-2,447.8%-625.6%-1,822.2%
1.2.2. Operating Ratio

Measures how efficient Theratech is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.10 means that the operating costs are $1.10 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Theratechnologies Inc.:

  • The MRQ is 1.102. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.335. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.102TTM1.335-0.233
TTM1.335YOY1.509-0.173
TTM1.3355Y1.323+0.013
5Y1.32310Y25.477-24.154
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1023.090-1.988
TTM1.3353.264-1.929
YOY1.5093.783-2.274
5Y1.3235.679-4.356
10Y25.4777.894+17.583

1.3. Liquidity of Theratechnologies Inc..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Theratech is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.34 means the company has $1.34 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Theratechnologies Inc.:

  • The MRQ is 1.338. The company is just able to pay all its short-term debts.
  • The TTM is 0.827. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ1.338TTM0.827+0.512
TTM0.827YOY1.314-0.487
TTM0.8275Y1.754-0.927
5Y1.75410Y1.809-0.056
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3383.914-2.576
TTM0.8274.220-3.393
YOY1.3145.388-4.074
5Y1.7546.045-4.291
10Y1.8096.406-4.597
1.3.2. Quick Ratio

Measures if Theratech is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Theratech to the Biotechnology industry mean.
  • A Quick Ratio of 0.40 means the company can pay off $0.40 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Theratechnologies Inc.:

  • The MRQ is 0.404. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.536. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.404TTM0.536-0.132
TTM0.536YOY1.056-0.520
TTM0.5365Y1.408-0.872
5Y1.40810Y1.363+0.046
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4043.572-3.168
TTM0.5363.998-3.462
YOY1.0565.390-4.334
5Y1.4085.969-4.561
10Y1.3636.287-4.924

1.4. Solvency of Theratechnologies Inc..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Theratech assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Theratech to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.27 means that Theratech assets are financed with 126.8% credit (debt) and the remaining percentage (100% - 126.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Theratechnologies Inc.:

  • The MRQ is 1.268. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.504. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.268TTM1.504-0.236
TTM1.504YOY1.115+0.389
TTM1.5045Y1.002+0.502
5Y1.00210Y0.778+0.225
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2680.336+0.932
TTM1.5040.334+1.170
YOY1.1150.269+0.846
5Y1.0020.366+0.636
10Y0.7780.390+0.388
1.4.2. Debt to Equity Ratio

Measures if Theratech is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Theratech to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Theratechnologies Inc.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY2.424-2.424
TTM-5Y4.356-4.356
5Y4.35610Y2.939+1.417
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.382-0.382
TTM-0.396-0.396
YOY2.4240.335+2.089
5Y4.3560.434+3.922
10Y2.9390.465+2.474

2. Market Valuation of Theratechnologies Inc.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Theratech generates.

  • Above 15 is considered overpriced but always compare Theratech to the Biotechnology industry mean.
  • A PE ratio of -6.52 means the investor is paying $-6.52 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Theratechnologies Inc.:

  • The EOD is -5.487. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.518. Based on the earnings, the company is expensive. -2
  • The TTM is -5.893. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.487MRQ-6.518+1.031
MRQ-6.518TTM-5.893-0.624
TTM-5.893YOY-5.591-0.302
TTM-5.8935Y-15.022+9.129
5Y-15.02210Y-1.834-13.187
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.487-2.259-3.228
MRQ-6.518-2.569-3.949
TTM-5.893-2.664-3.229
YOY-5.591-4.120-1.471
5Y-15.022-6.258-8.764
10Y-1.834-6.171+4.337
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Theratechnologies Inc.:

  • The EOD is -2.696. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.203. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.594. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.696MRQ-3.203+0.507
MRQ-3.203TTM-2.594-0.609
TTM-2.594YOY-22.123+19.530
TTM-2.5945Y-60.006+57.412
5Y-60.00610Y-44.988-15.018
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.696-2.924+0.228
MRQ-3.203-3.246+0.043
TTM-2.594-3.488+0.894
YOY-22.123-5.620-16.503
5Y-60.006-8.315-51.691
10Y-44.988-8.826-36.162
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Theratech is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -3.44 means the investor is paying $-3.44 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Theratechnologies Inc.:

  • The EOD is -2.897. Based on the equity, the company is expensive. -2
  • The MRQ is -3.441. Based on the equity, the company is expensive. -2
  • The TTM is -2.052. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.897MRQ-3.441+0.544
MRQ-3.441TTM-2.052-1.389
TTM-2.052YOY-3.978+1.926
TTM-2.0525Y8.007-10.059
5Y8.00710Y8.227-0.220
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.8971.851-4.748
MRQ-3.4412.090-5.531
TTM-2.0522.095-4.147
YOY-3.9782.844-6.822
5Y8.0073.466+4.541
10Y8.2273.815+4.412
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Theratechnologies Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.624-0.075+112%-0.146+123%-0.063+110%-0.025+104%
Book Value Per Share---0.625-0.894+43%-0.152-76%0.032-2027%0.225-378%
Current Ratio--1.3380.827+62%1.314+2%1.754-24%1.809-26%
Debt To Asset Ratio--1.2681.504-16%1.115+14%1.002+27%0.778+63%
Debt To Equity Ratio----0%2.424-100%4.356-100%2.939-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.082-0.138+68%-0.171+107%-0.117+41%-0.074-10%
Free Cash Flow Per Share---0.168-0.042-75%-0.057-66%-0.049-71%-0.025-85%
Free Cash Flow To Equity Per Share--0.5230.069+658%-0.022+104%-0.004+101%0.025+1961%
Gross Profit Margin--1.0001.163-14%1.910-48%2.229-55%1.509-34%
Intrinsic Value_10Y_max---3.190--------
Intrinsic Value_10Y_min---4.887--------
Intrinsic Value_1Y_max---0.131--------
Intrinsic Value_1Y_min---0.256--------
Intrinsic Value_3Y_max---0.537--------
Intrinsic Value_3Y_min---0.976--------
Intrinsic Value_5Y_max---1.117--------
Intrinsic Value_5Y_min---1.918--------
Market Cap83223800.000-19%98857040.85083982091.640+18%302738581.018-67%298665283.682-67%302246427.937-67%
Net Profit Margin---0.117-0.312+166%-0.600+411%-0.382+225%-27.782+23549%
Operating Margin----0.1720%-0.5090%-0.2870%-24.4780%
Operating Ratio--1.1021.335-17%1.509-27%1.323-17%25.477-96%
Pb Ratio-2.897+16%-3.441-2.052-40%-3.978+16%8.007-143%8.227-142%
Pe Ratio-5.487+16%-6.518-5.893-10%-5.591-14%-15.022+130%-1.834-72%
Price Per Share1.810-19%2.1501.470+46%3.183-32%3.630-41%3.911-45%
Price To Free Cash Flow Ratio-2.696+16%-3.203-2.594-19%-22.123+591%-60.006+1773%-44.988+1305%
Price To Total Gains Ratio2.902-19%3.447-61.809+1893%-29.764+963%-76.390+2316%-87.159+2628%
Quick Ratio--0.4040.536-25%1.056-62%1.408-71%1.363-70%
Return On Assets---0.035-0.082+130%-0.121+242%-0.069+96%-0.051+44%
Return On Equity----0%-0.2220%-0.2850%-0.1790%
Total Gains Per Share--0.624-0.075+112%-0.146+123%-0.063+110%-0.025+104%
Usd Book Value---20866179.955-34097757.604+63%-10526822.818-50%5490844.772-480%13433201.760-255%
Usd Book Value Change Per Share--0.453-0.054+112%-0.106+123%-0.045+110%-0.018+104%
Usd Book Value Per Share---0.454-0.649+43%-0.111-76%0.024-2027%0.164-378%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.060-0.100+68%-0.124+107%-0.085+41%-0.054-10%
Usd Free Cash Flow---5604973.878-1873656.983-67%-3918532.620-30%-2920065.413-48%-1454482.524-74%
Usd Free Cash Flow Per Share---0.122-0.031-75%-0.041-66%-0.035-71%-0.018-85%
Usd Free Cash Flow To Equity Per Share--0.3800.050+658%-0.016+104%-0.003+101%0.018+1961%
Usd Market Cap60453768.320-19%71809754.47361004591.367+18%219909305.251-67%216950462.066-67%219551805.253-67%
Usd Price Per Share1.315-19%1.5621.068+46%2.312-32%2.637-41%2.841-45%
Usd Profit---2754495.725-5988153.728+117%-11807088.435+329%-6902836.274+151%-4101937.784+49%
Usd Revenue--23447707.34620437258.479+15%20010586.592+17%18042346.924+30%12347456.064+90%
Usd Total Gains Per Share--0.453-0.054+112%-0.106+123%-0.045+110%-0.018+104%
 EOD+1 -7MRQTTM+25 -6YOY+18 -145Y+17 -1510Y+16 -16

3.2. Fundamental Score

Let's check the fundamental score of Theratechnologies Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.487
Price to Book Ratio (EOD)Between0-1-2.897
Net Profit Margin (MRQ)Greater than0-0.117
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.404
Current Ratio (MRQ)Greater than11.338
Debt to Asset Ratio (MRQ)Less than11.268
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.035
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Theratechnologies Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.854
Ma 20Greater thanMa 501.961
Ma 50Greater thanMa 1001.960
Ma 100Greater thanMa 2002.134
OpenGreater thanClose1.800
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-11-302023-02-282023-05-312023-08-312023-11-30
Net Working Capital  -56,30739,772-16,535-11,251-27,785-50,795-78,580100,60722,027



Latest Balance Sheet

Balance Sheet of 2023-11-30. Currency in USD. All numbers in thousands.

Summary
Total Assets77,769
Total Liabilities98,639
Total Stockholder Equity-20,870
 As reported
Total Liabilities 98,639
Total Stockholder Equity+ -20,870
Total Assets = 77,769

Assets

Total Assets77,769
Total Current Assets63,297
Long-term Assets14,472
Total Current Assets
Cash And Cash Equivalents 34,097
Short-term Investments 6,290
Net Receivables 12,798
Inventory 6,066
Total Current Assets  (as reported)63,297
Total Current Assets  (calculated)59,251
+/- 4,046
Long-term Assets
Property Plant Equipment 1,976
Intangible Assets 12,496
Long-term Assets  (as reported)14,472
Long-term Assets  (calculated)14,472
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities47,294
Long-term Liabilities51,345
Total Stockholder Equity-20,870
Total Current Liabilities
Short Long Term Debt 7,286
Accounts payable 6,990
Other Current Liabilities 1,475
Total Current Liabilities  (as reported)47,294
Total Current Liabilities  (calculated)15,751
+/- 31,543
Long-term Liabilities
Long term Debt 50,688
Capital Lease Obligations Min Short Term Debt994
Long-term Liabilities  (as reported)51,345
Long-term Liabilities  (calculated)51,682
+/- 337
Total Stockholder Equity
Total Stockholder Equity (as reported)-20,870
Total Stockholder Equity (calculated)0
+/- 20,870
Other
Capital Stock363,927
Common Stock Shares Outstanding 45,980
Net Debt 23,877
Net Invested Capital 37,104
Net Working Capital 16,003
Property Plant and Equipment Gross 3,226



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-11-302023-08-312023-05-312023-02-282022-11-302022-08-312022-05-312022-02-282021-11-302021-08-312021-05-312021-02-282020-11-302020-08-312020-05-312020-02-292019-11-302019-08-312019-05-312019-02-282018-11-302018-08-312018-05-312018-02-282017-11-302017-08-312017-05-312017-02-282016-11-302016-08-312016-05-312016-02-292015-11-302015-08-312015-05-312015-02-282014-11-302014-08-312014-05-312014-02-282013-11-302013-08-312013-05-312013-02-282012-11-302012-08-312012-05-312012-02-292011-11-302011-08-312011-05-312011-02-282010-11-302010-08-312010-05-312010-02-282009-11-302009-08-312009-05-312009-02-282008-11-302008-08-312008-05-312008-02-292007-11-302007-08-312007-05-312007-02-282006-11-302006-08-312006-05-312006-02-282005-11-302005-08-312005-05-312005-02-282004-11-302004-08-312004-05-312004-02-292003-11-302003-08-312003-05-312003-02-282002-11-302002-08-312002-05-312002-02-282001-11-302001-08-312001-05-312001-02-282000-11-302000-08-312000-05-312000-02-291999-11-301999-08-311999-05-311999-02-281998-11-301998-08-311998-05-311998-02-281997-11-301997-08-311997-05-311997-02-28
> Total Assets 
11,399
10,086
9,719
8,503
7,518
13,868
12,782
12,435
11,734
15,124
18,869
18,404
20,192
41,045
47,972
54,992
52,977
53,266
93,270
90,376
102,568
99,192
95,019
89,781
88,915
89,059
83,369
72,875
77,593
69,845
58,540
57,227
63,114
50,861
49,040
45,931
43,203
57,126
51,396
44,650
84,561
85,365
80,143
74,553
94,425
84,276
68,156
43,598
61,968
65,036
68,107
65,696
58,880
54,835
47,868
70,279
66,438
62,965
57,802
51,204
46,006
41,601
41,406
36,575
32,600
28,801
25,728
23,401
19,046
34,306
30,197
28,508
29,066
30,695
39,175
37,456
37,577
39,934
38,695
39,429
52,441
56,297
57,587
59,286
56,555
54,446
108,523
111,253
116,490
110,635
108,070
117,555
110,667
111,754
101,504
100,142
135,080
133,523
127,002
119,212
108,670
95,359
95,855
93,260
79,240
68,733
56,686
77,769
77,76956,68668,73379,24093,26095,85595,359108,670119,212127,002133,523135,080100,142101,504111,754110,667117,555108,070110,635116,490111,253108,52354,44656,55559,28657,58756,29752,44139,42938,69539,93437,57737,45639,17530,69529,06628,50830,19734,30619,04623,40125,72828,80132,60036,57541,40641,60146,00651,20457,80262,96566,43870,27947,86854,83558,88065,69668,10765,03661,96843,59868,15684,27694,42574,55380,14385,36584,56144,65051,39657,12643,20345,93149,04050,86163,11457,22758,54069,84577,59372,87583,36989,05988,91589,78195,01999,192102,56890,37693,27053,26652,97754,99247,97241,04520,19218,40418,86915,12411,73412,43512,78213,8687,5188,5039,71910,08611,399
   > Total Current Assets 
10,960
9,578
9,359
7,730
6,745
12,907
11,896
11,523
10,739
14,107
16,928
16,434
18,194
31,635
22,453
20,983
14,976
19,351
41,584
35,339
41,222
33,603
28,480
28,483
38,065
42,717
36,608
32,760
39,791
28,604
14,603
17,553
20,059
19,193
18,298
14,720
14,345
19,939
20,544
18,817
60,219
35,856
36,496
34,420
46,945
38,753
27,578
11,418
17,683
20,710
26,496
15,515
14,219
15,540
9,673
33,888
18,670
19,207
18,267
17,846
20,218
18,726
19,556
17,202
15,386
16,123
14,016
12,301
10,041
14,608
12,910
15,238
16,207
18,199
27,145
25,741
22,939
20,221
19,707
21,155
33,751
30,516
31,475
34,653
33,408
32,635
68,486
73,696
72,486
69,156
68,810
76,181
68,795
72,163
63,994
64,807
101,859
102,439
97,767
91,908
83,490
78,302
77,872
73,370
60,936
51,129
40,565
63,297
63,29740,56551,12960,93673,37077,87278,30283,49091,90897,767102,439101,85964,80763,99472,16368,79576,18168,81069,15672,48673,69668,48632,63533,40834,65331,47530,51633,75121,15519,70720,22122,93925,74127,14518,19916,20715,23812,91014,60810,04112,30114,01616,12315,38617,20219,55618,72620,21817,84618,26719,20718,67033,8889,67315,54014,21915,51526,49620,71017,68311,41827,57838,75346,94534,42036,49635,85660,21918,81720,54419,93914,34514,72018,29819,19320,05917,55314,60328,60439,79132,76036,60842,71738,06528,48328,48033,60341,22235,33941,58419,35114,97620,98322,45331,63518,19416,43416,92814,10710,73911,52311,89612,9076,7457,7309,3599,57810,960
       Cash And Cash Equivalents 
9,645
7,981
8,351
6,957
5,691
11,328
10,251
10,352
9,347
13,157
15,991
272
1,930
12,147
11,757
883
1,174
7,125
20,517
1,552
13,062
7,105
9,568
125
3,332
4,357
1,901
41
15,942
2,634
346
367
4,500
6,056
4,015
931
62
1,549
1,399
14
47,005
11,825
6,193
2,577
17,741
8,028
9,051
107
5,428
3,517
11,618
1,436
3,170
3,314
2,235
26,139
544
1,034
516
2,478
63
1,011
2,562
1,522
77
391
1,541
911
213
286
2,320
606
3,169
3,679
11,462
11,480
8,351
3,627
244
788
5,505
3,023
1,020
1,368
1,359
2,351
34,484
39,045
40,194
30,089
31,034
28,661
23,600
21,440
17,242
12,737
49,116
38,235
32,446
20,399
14,342
13,200
23,416
23,856
20,023
16,957
14,966
34,097
34,09714,96616,95720,02323,85623,41613,20014,34220,39932,44638,23549,11612,73717,24221,44023,60028,66131,03430,08940,19439,04534,4842,3511,3591,3681,0203,0235,5057882443,6278,35111,48011,4623,6793,1696062,3202862139111,541391771,5222,5621,011632,4785161,03454426,1392,2353,3143,1701,43611,6183,5175,4281079,0518,02817,7412,5776,19311,82547,005141,3991,549629314,0156,0564,5003673462,63415,942411,9014,3573,3321259,5687,10513,0621,55220,5177,1251,17488311,75712,1471,93027215,99113,1579,34710,35210,25111,3285,6916,9578,3517,9819,645
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
14,872
14,403
17,553
9,174
17,861
11,463
9,987
18,715
31,254
24,038
22,478
14,686
24,984
30,226
33,623
31,055
30,280
21,031
22,576
11,694
14,749
12,922
9,305
9,931
10,715
10,725
14,150
14,888
15,789
9,093
18,632
25,321
27,452
24,977
26,477
15,891
8,821
7,708
11,721
8,730
9,489
5,959
5,016
1,598
1,824
10,558
6,737
1,185
728
3,611
156
828
150
111
111
69
93
49
37
32
2,169
0
0
0
0
15
21
3,208
4,945
13,378
10,929
13,441
16,554
17,535
10,797
10,808
9,702
9,826
10,122
10,933
11,964
10,979
10,203
9,605
8,031
7,600
18,479
19,138
19,955
19,941
19,291
13,046
9,214
9,133
8,412
7,908
6,290
6,2907,9088,4129,1339,21413,04619,29119,94119,95519,13818,4797,6008,0319,60510,20310,97911,96410,93310,1229,8269,70210,80810,79717,53516,55413,44110,92913,3784,9453,208211500002,16932374993691111111508281563,6117281,1856,73710,5581,8241,5985,0165,9599,4898,73011,7217,7088,82115,89126,47724,97727,45225,32118,6329,09315,78914,88814,15010,72510,7159,9319,30512,92214,74911,69422,57621,03130,28031,05533,62330,22624,98414,68622,47824,03831,25418,7159,98711,46317,8619,17417,55314,40314,87200000000000
       Net Receivables 
877
1,161
720
703
984
1,373
1,455
781
1,061
610
468
1,019
1,585
1,535
1,131
1,544
1,576
1,169
1,256
1,376
2,755
2,484
2,190
1,753
1,653
1,776
773
1,217
1,485
1,938
1,218
968
1,152
1,268
1,533
1,058
1,331
1,487
1,699
1,927
1,830
2,235
1,808
1,868
2,287
2,945
1,919
1,928
2,372
2,890
3,092
1,930
2,012
2,064
608
484
1,920
2,347
3,255
2,063
769
1,660
412
1,600
1,265
2,094
694
461
263
3,979
70
2,059
2,029
3,341
4,564
3,441
4,340
5,570
5,304
4,994
4,587
5,935
6,788
7,566
5,090
7,826
11,637
10,966
7,986
13,421
11,374
10,116
9,886
12,191
8,475
13,185
11,236
10,827
13,513
11,880
13,948
12,853
11,530
12,344
10,383
13,603
9,115
12,798
12,7989,11513,60310,38312,34411,53012,85313,94811,88013,51310,82711,23613,1858,47512,1919,88610,11611,37413,4217,98610,96611,6377,8265,0907,5666,7885,9354,5874,9945,3045,5704,3403,4414,5643,3412,0292,059703,9792634616942,0941,2651,6004121,6607692,0633,2552,3471,9204846082,0642,0121,9303,0922,8902,3721,9281,9192,9452,2871,8681,8082,2351,8301,9271,6991,4871,3311,0581,5331,2681,1529681,2181,9381,4851,2177731,7761,6531,7532,1902,4842,7551,3761,2561,1691,5761,5441,1311,5351,5851,0194686101,0617811,4551,3739847037201,161877
       Inventory 
219
218
144
70
70
69
127
260
199
136
67
68
69
200
194
491
569
836
876
730
967
1,156
1,475
1,274
2,374
2,397
2,264
763
681
664
1,057
1,299
1,255
2,088
2,230
1,652
1,787
2,174
2,048
745
1,858
2,446
2,265
2,109
1,184
596
240
242
1,256
1,462
1,455
2,375
2,142
4,261
4,324
4,234
4,718
8,004
10,827
10,006
13,651
13,789
14,019
12,875
13,031
12,381
10,770
10,356
8,990
9,339
9,637
9,270
9,413
9,961
9,653
9,502
8,917
9,680
9,643
9,129
8,726
8,849
8,193
7,257
7,390
8,633
8,642
11,098
11,502
12,861
12,860
20,929
20,670
24,735
25,669
25,145
27,344
28,578
27,293
29,141
26,134
24,976
23,141
19,688
15,110
9,162
6,723
6,066
6,0666,7239,16215,11019,68823,14124,97626,13429,14127,29328,57827,34425,14525,66924,73520,67020,92912,86012,86111,50211,0988,6428,6337,3907,2578,1938,8498,7269,1299,6439,6808,9179,5029,6539,9619,4139,2709,6379,3398,99010,35610,77012,38113,03112,87514,01913,78913,65110,00610,8278,0044,7184,2344,3244,2612,1422,3751,4551,4621,2562422405961,1842,1092,2652,4461,8587452,0482,1741,7871,6522,2302,0881,2551,2991,0576646817632,2642,3972,3741,2741,4751,156967730876836569491194200696867136199260127697070144218219
       Other Current Assets 
219
218
144
0
0
137
63
130
133
203
401
204
207
200
196
205
195
233
221
427
399
380
561
347
480
563
615
460
652
791
288
170
232
476
588
364
442
579
509
343
432
718
909
414
757
707
476
320
919
1,119
1,600
286
936
885
908
1,207
929
1,084
2,484
2,571
2,123
2,110
1,735
1,056
902
1,147
942
480
526
967
851
1,134
1,597
1,218
1,466
1,318
1,316
1,323
1,309
1,298
1,556
1,780
2,033
1,908
2,035
3,028
2,915
2,885
2,978
2,663
2,609
4,511
3,660
3,594
3,003
5,709
6,563
6,320
5,377
11,485
9,125
7,982
6,739
8,268
6,287
249
65
0
0652496,2878,2686,7397,9829,12511,4855,3776,3206,5635,7093,0033,5943,6604,5112,6092,6632,9782,8852,9153,0282,0351,9082,0331,7801,5561,2981,3091,3231,3161,3181,4661,2181,5971,1348519675264809421,1479021,0561,7352,1102,1232,5712,4841,0849291,2079088859362861,6001,1199193204767077574149097184323435095794423645884762321702887916524606155634803475613803994272212331952051962002072044012031331306313700144218219
   > Long-term Assets 
438
508
360
773
773
961
886
911
994
1,017
1,940
1,969
1,999
9,410
25,519
34,010
38,001
33,916
51,686
55,037
61,346
65,590
66,539
61,298
50,850
46,342
46,762
40,115
37,803
41,241
43,937
39,674
43,054
31,668
30,742
31,211
28,858
37,187
30,852
25,833
24,342
49,509
43,647
40,133
47,480
45,523
40,578
32,180
44,286
44,326
41,611
50,182
44,661
39,295
38,195
36,391
47,768
43,758
39,535
33,358
25,789
22,875
21,850
19,373
17,214
12,678
11,711
11,099
9,005
19,698
17,286
13,270
12,858
12,497
12,030
11,716
14,638
19,713
18,988
18,274
18,689
25,781
26,112
24,633
23,147
21,811
40,037
37,556
44,004
41,479
39,260
41,374
41,872
39,591
37,510
35,335
33,221
31,084
29,235
27,304
25,180
17,057
17,983
19,890
18,304
17,604
16,121
14,472
14,47216,12117,60418,30419,89017,98317,05725,18027,30429,23531,08433,22135,33537,51039,59141,87241,37439,26041,47944,00437,55640,03721,81123,14724,63326,11225,78118,68918,27418,98819,71314,63811,71612,03012,49712,85813,27017,28619,6989,00511,09911,71112,67817,21419,37321,85022,87525,78933,35839,53543,75847,76836,39138,19539,29544,66150,18241,61144,32644,28632,18040,57845,52347,48040,13343,64749,50924,34225,83330,85237,18728,85831,21130,74231,66843,05439,67443,93741,24137,80340,11546,76246,34250,85061,29866,53965,59061,34655,03751,68633,91638,00134,01025,5199,4101,9991,9691,9401,017994911886961773773360508438
       Property Plant Equipment 
365
363
288
281
351
481
380
391
398
407
468
407
551
801
681
957
1,246
1,274
1,329
1,737
2,454
4,144
4,547
4,824
5,073
5,064
4,726
4,102
3,801
3,509
1,514
1,881
1,753
1,817
1,869
6,679
1,722
1,675
1,538
1,384
1,408
1,539
1,629
1,721
1,689
1,542
1,321
1,046
982
1,111
1,030
1,162
1,150
1,100
1,043
1,040
1,035
989
1,035
938
838
752
717
405
352
325
293
265
240
233
220
127
86
84
81
83
89
95
99
35
63
58
52
48
45
60
54
102
841
1,180
1,130
1,071
3,858
3,707
3,642
3,483
3,346
3,224
3,050
2,854
2,718
2,919
3,175
3,089
2,230
2,401
2,192
1,976
1,9762,1922,4012,2303,0893,1752,9192,7182,8543,0503,2243,3463,4833,6423,7073,8581,0711,1301,1808411025460454852586335999589838184861272202332402652933253524057177528389381,0359891,0351,0401,0431,1001,1501,1621,0301,1119821,0461,3211,5421,6891,7211,6291,5391,4081,3841,5381,6751,7226,6791,8691,8171,7531,8811,5143,5093,8014,1024,7265,0645,0734,8244,5474,1442,4541,7371,3291,2741,246957681801551407468407398391380481351281288363365
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,900
4,694
10,807
11,323
9,866
8,330
7,195
7,667
6,913
3,853
2,851
2,168
619
191
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000001916192,1682,8513,8536,9137,6677,1958,3309,86611,32310,8074,6943,9000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
281
351
412
380
391
464
475
870
1,358
1,309
1,201
503
5,518
0
27,053
0
0
0
0
13,008
13,454
0
0
0
0
0
0
0
6,180
0
0
0
712
5,695
5,773
5,687
5,435
5,205
5,639
7,608
5,895
5,891
5,694
5,235
482
1,739
1,953
0
0
0
39
39
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,671
14,243
13,143
15,981
15,427
0
11,633
15,250
21,106
15,752
15,336
19,876
17,701
17,090
16,918
21,182
20,852
20,368
15,138
23,443
22,802
22,537
39,684
37,823
35,884
33,868
31,852
29,875
27,860
25,844
23,829
21,813
13,491
12,849
15,009
14,271
13,531
12,856
12,496
12,49612,85613,53114,27115,00912,84913,49121,81323,82925,84427,86029,87531,85233,86835,88437,82339,68422,53722,80223,44315,13820,36820,85221,18216,91817,09017,70119,87615,33615,75221,10615,25011,633015,42715,98113,14314,24314,6710000000000000039390001,9531,7394825,2355,6945,8915,8957,6085,6395,2055,4355,6875,7735,6957120006,180000000013,45413,008000027,05305,5185031,2011,3091,358870475464391380412351281000
       Long-term Assets Other 
73
145
72
211
70
69
127
130
133
136
602
204
138
7,408
24,335
27,535
36,755
5,588
50,357
53,300
58,892
61,446
48,984
43,020
45,777
41,279
42,036
36,013
34,001
37,732
42,423
31,613
41,301
29,851
28,873
23,820
21,441
29,740
23,628
19,014
17,729
42,331
34,410
32,517
39,900
38,287
34,022
30,651
0
0
0
39
39
0
0
0
0
0
0
0
0
0
0
0
0
0
0
203
377
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,397
17,110
15,867
14,646
13,425
12,204
10,983
9,763
8,543
0
6,102
4,882
4,002
621
1,869
647
1,959
1,792
1,803
0
0
0
0001,8031,7921,9596471,8696214,0024,8826,10208,5439,76310,98312,20413,42514,64615,86717,11018,3970000000000000000037720300000000000000393900030,65134,02238,28739,90032,51734,41042,33117,72919,01423,62829,74021,44123,82028,87329,85141,30131,61342,42337,73234,00136,01342,03641,27945,77743,02048,98461,44658,89253,30050,3575,58836,75527,53524,3357,40813820460213613313012769702117214573
> Total Liabilities 
804
871
1,512
1,476
1,476
1,785
1,519
1,497
1,392
1,356
1,271
1,494
1,861
9,544
9,167
16,458
15,863
13,712
18,030
19,429
16,599
9,383
9,461
10,270
9,530
9,451
9,598
8,393
5,259
4,157
2,434
4,208
4,551
3,283
3,092
3,972
4,527
4,162
5,100
5,688
5,737
5,938
9,000
8,609
9,059
11,545
10,318
5,796
25,778
27,018
24,499
24,997
21,794
22,942
18,291
18,631
18,569
20,140
18,966
16,008
16,758
14,612
14,130
13,753
8,619
6,407
5,705
5,949
5,598
19,646
19,633
21,639
22,995
23,936
24,680
22,481
22,681
21,052
18,981
19,414
22,220
22,759
21,411
25,777
24,908
24,045
72,828
76,198
82,366
79,277
78,048
92,721
90,005
96,332
92,978
96,918
94,678
98,361
100,130
101,452
98,510
107,003
113,915
115,831
111,551
110,264
98,390
98,639
98,63998,390110,264111,551115,831113,915107,00398,510101,452100,13098,36194,67896,91892,97896,33290,00592,72178,04879,27782,36676,19872,82824,04524,90825,77721,41122,75922,22019,41418,98121,05222,68122,48124,68023,93622,99521,63919,63319,6465,5985,9495,7056,4078,61913,75314,13014,61216,75816,00818,96620,14018,56918,63118,29122,94221,79424,99724,49927,01825,7785,79610,31811,5459,0598,6099,0005,9385,7375,6885,1004,1624,5273,9723,0923,2834,5514,2082,4344,1575,2598,3939,5989,4519,53010,2709,4619,38316,59919,42918,03013,71215,86316,4589,1679,5441,8611,4941,2711,3561,3921,4971,5191,7851,4761,4761,512871804
   > Total Current Liabilities 
804
798
864
843
913
1,167
1,012
1,042
862
949
937
1,087
1,585
2,002
1,587
2,623
2,070
2,084
3,503
4,976
5,089
6,091
4,974
5,854
4,858
4,410
4,630
5,495
5,259
4,157
2,434
4,208
4,551
3,283
3,092
3,972
4,527
4,162
5,100
5,688
5,737
5,938
9,000
8,609
9,059
11,545
10,318
5,796
10,950
11,317
10,436
12,053
10,397
13,171
10,064
11,598
12,139
12,979
12,785
11,114
9,728
9,051
9,654
6,447
6,314
4,575
4,360
4,380
4,396
7,734
7,840
9,877
10,351
14,564
14,594
12,603
12,812
13,066
11,619
11,487
12,773
16,592
17,924
22,247
21,369
24,045
23,721
26,904
29,462
25,716
27,440
37,144
31,525
37,548
33,700
41,919
39,300
42,555
44,070
45,076
41,782
49,923
74,495
114,279
72,949
71,316
97,656
47,294
47,29497,65671,31672,949114,27974,49549,92341,78245,07644,07042,55539,30041,91933,70037,54831,52537,14427,44025,71629,46226,90423,72124,04521,36922,24717,92416,59212,77311,48711,61913,06612,81212,60314,59414,56410,3519,8777,8407,7344,3964,3804,3604,5756,3146,4479,6549,0519,72811,11412,78512,97912,13911,59810,06413,17110,39712,05310,43611,31710,9505,79610,31811,5459,0598,6099,0005,9385,7375,6885,1004,1624,5273,9723,0923,2834,5514,2082,4344,1575,2595,4954,6304,4104,8585,8544,9746,0915,0894,9763,5032,0842,0702,6231,5872,0021,5851,0879379498621,0421,0121,167913843864798804
       Short-term Debt 
0
0
0
0
0
69
63
65
66
68
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,989
3,682
3,327
7,416
0
4,391
5,027
3,725
0
0
5,033
0
4,250
4,676
0
4,617
63,778
0
3,452
0
0
0
363
373
412
425
445
471
462
463
476
479
27,113
65,265
27,439
0
0
0
00027,43965,26527,1134794764634624714454254123733630003,452063,7784,61704,6764,25005,033003,7255,0274,39107,4163,3273,6822,989000000000000000000000000000000000000000000000000000000000000686665636900000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
63,778
0
3,452
0
0
0
0
0
0
0
0
0
0
0
0
0
26,645
64,789
27,110
27,373
57,143
7,286
7,28657,14327,37327,11064,78926,64500000000000003,452063,77800000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
804
798
864
843
913
1,167
949
911
795
814
870
1,087
1,585
2,002
1,587
2,623
2,070
2,084
3,503
4,976
5,089
6,091
4,974
5,854
4,858
4,410
4,630
5,495
5,259
4,157
2,434
4,208
4,551
3,283
3,092
3,972
4,527
4,162
5,100
5,688
5,737
5,938
9,000
8,609
9,059
11,545
10,318
5,796
0
0
0
0
0
0
0
0
0
0
0
3,321
0
1,147
1,623
1,484
642
733
470
478
3,238
5,450
5,089
1,592
6,816
7,071
7,775
2,352
8,744
9,839
8,034
2,318
8,423
12,940
14,050
5,415
16,764
19,410
22,730
15,604
24,312
20,633
21,780
13,106
24,783
30,606
30,827
17,510
30,603
33,180
35,300
15,526
35,924
43,555
41,076
12,886
34,083
33,605
30,457
6,990
6,99030,45733,60534,08312,88641,07643,55535,92415,52635,30033,18030,60317,51030,82730,60624,78313,10621,78020,63324,31215,60422,73019,41016,7645,41514,05012,9408,4232,3188,0349,8398,7442,3527,7757,0716,8161,5925,0895,4503,2384784707336421,4841,6231,14703,321000000000005,79610,31811,5459,0598,6099,0005,9385,7375,6885,1004,1624,5273,9723,0923,2834,5514,2082,4344,1575,2595,4954,6304,4104,8585,8544,9746,0915,0894,9763,5032,0842,0702,6231,5872,0021,5851,0878708147959119491,167913843864798804
       Other Current Liabilities 
0
0
0
0
0
-69
0
65
0
68
67
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,549
5,030
4,182
5,579
3,875
6,677
3,605
4,882
5,139
8,594
8,411
3,649
5,416
3,746
3,719
3,097
3,853
2,037
2,129
2,697
0
2,278
-240
4,602
208
71
6,757
5,842
-976
-516
3,568
9,095
-725
3,611
-390
12,157
4,604
18
991
11,273
1,655
5,013
5,627
23,968
6,342
6,541
2,412
23,918
8,180
8,854
8,239
29,033
5,328
5,835
6,252
36,090
11,389
9,941
9,644
1,475
1,4759,6449,94111,38936,0906,2525,8355,32829,0338,2398,8548,18023,9182,4126,5416,34223,9685,6275,0131,65511,273991184,60412,157-3903,611-7259,0953,568-516-9765,8426,757712084,602-2402,27802,6972,1292,0373,8533,0973,7193,7465,4163,6498,4118,5945,1394,8823,6056,6773,8755,5794,1825,0305,549000000000000000000000000000000000000067680650-6900000
   > Long-term Liabilities 
0
73
648
632
562
618
506
456
530
407
335
407
276
7,542
7,580
13,835
13,792
11,628
14,526
14,453
11,510
3,292
4,487
4,416
4,671
5,041
4,967
2,898
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,828
15,701
14,063
12,944
11,398
9,771
8,227
7,034
6,429
7,161
6,181
4,894
7,030
5,561
4,476
7,307
2,305
1,833
1,345
1,569
1,203
11,912
11,793
11,761
12,644
9,372
10,086
9,877
9,869
7,986
7,362
7,927
9,447
6,167
3,486
3,530
3,539
0
49,107
49,294
52,904
53,561
50,608
55,577
58,480
58,784
59,278
54,999
55,378
55,806
56,060
56,376
56,728
57,080
39,420
1,552
38,602
38,948
734
51,345
51,34573438,94838,6021,55239,42057,08056,72856,37656,06055,80655,37854,99959,27858,78458,48055,57750,60853,56152,90449,29449,10703,5393,5303,4866,1679,4477,9277,3627,9869,8699,87710,0869,37212,64411,76111,79311,9121,2031,5691,3451,8332,3057,3074,4765,5617,0304,8946,1817,1616,4297,0348,2279,77111,39812,94414,06315,70114,828000000000000000000002,8984,9675,0414,6714,4164,4873,29211,51014,45314,52611,62813,79213,8357,5807,542276407335407530456506618562632648730
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
52,903
53,315
50,349
55,311
58,451
58,755
59,234
54,958
55,316
55,738
55,985
56,282
56,630
56,972
39,320
1,446
38,546
38,902
684
0
068438,90238,5461,44639,32056,97256,63056,28255,98555,73855,31654,95859,23458,75558,45155,31150,34953,31552,9030000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,650
12,461
8,308
4,401
4,543
4,521
0
0
0
3,314
3,593
259
4,836
4,618
4,631
4,646
41
62
68
75
94
98
108
100
106
0
46
50
0
0504601061001089894756862414,6464,6314,6184,8362593,5933,3140004,5214,5434,4018,30812,46110,6500000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
341
621
649
647
1,959
1,792
0
1,672
1,073
0
01,0731,67201,7921,95964764962134100000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
10,595
9,215
8,207
7,027
6,043
12,083
11,263
10,938
10,341
13,767
17,597
16,910
18,331
31,501
38,805
38,534
37,114
39,555
59,691
56,014
71,673
75,262
70,696
65,586
65,407
65,738
60,690
54,263
62,368
56,971
56,106
53,020
58,562
47,577
45,948
41,959
38,676
52,964
46,295
38,962
78,824
79,427
71,143
65,944
85,366
72,732
57,838
37,802
36,191
38,017
43,608
40,700
37,086
31,893
29,577
51,648
47,869
42,824
38,835
35,196
29,249
26,989
27,276
22,822
23,980
22,394
20,023
17,452
13,448
14,661
10,563
6,869
6,070
6,760
14,495
14,976
14,896
18,882
19,713
20,015
30,221
33,538
36,177
33,508
31,647
30,401
35,695
35,055
34,124
31,358
30,022
24,834
20,662
15,422
8,526
3,224
40,402
35,162
26,872
17,760
10,160
-11,644
-18,060
-22,571
-32,311
-41,531
-41,704
-20,870
-20,870-41,704-41,531-32,311-22,571-18,060-11,64410,16017,76026,87235,16240,4023,2248,52615,42220,66224,83430,02231,35834,12435,05535,69530,40131,64733,50836,17733,53830,22120,01519,71318,88214,89614,97614,4956,7606,0706,86910,56314,66113,44817,45220,02322,39423,98022,82227,27626,98929,24935,19638,83542,82447,86951,64829,57731,89337,08640,70043,60838,01736,19137,80257,83872,73285,36665,94471,14379,42778,82438,96246,29552,96438,67641,95945,94847,57758,56253,02056,10656,97162,36854,26360,69065,73865,40765,58670,69675,26271,67356,01459,69139,55537,11438,53438,80531,50118,33116,91017,59713,76710,34110,93811,26312,0836,0437,0278,2079,21510,595
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
274,356
272,511
266,431
264,554
252,433
258,849
258,311
245,209
224,487
226,001
219,752
217,629
214,738
223,386
222,565
216,986
233,801
238,795
260,237
255,389
257,324
259,479
257,626
252,483
286,905
287,035
287,035
287,035
287,035
287,312
287,312
287,312
333,369
335,011
335,716
335,752
335,752
335,752
335,762
338,751
338,751
338,751
338,767
0
0338,767338,751338,751338,751335,762335,752335,752335,752335,716335,011333,369287,312287,312287,312287,035287,035287,035287,035286,905252,483257,626259,479257,324255,389260,237238,795233,801216,986222,565223,386214,738217,629219,752226,001224,487245,209258,311258,849252,433264,554266,431272,511274,3560000000000000000000000000000000000000000000000000000000000000000
   Retained Earnings -408,659-403,851-403,105-393,092-382,649-374,556-367,007-344,280-335,248-325,347-315,833-309,436-300,129-294,580-287,812-282,006-277,462-271,007-269,368-266,194-230,686-234,843-237,161-237,463-233,682-234,894-217,957-215,693-208,901-214,534-216,006-207,533-210,212-212,632-226,489-225,626-245,654-255,451-251,933-246,594-255,106-254,452-258,381-258,780-268,572-264,282-254,005-261,841-244,863-256,560-252,842-246,470-230,614-241,658-239,946-236,090-230,582-218,388-224,783-188,715-183,775-200,311-202,722-194,029-177,250-158,203-147,105-127,507-119,635-117,262-111,139-100,793-93,531-87,214-78,392-69,396-79,922-64,019-58,636-55,442-53,517-40,140-35,864-28,505-23,449-18,537-15,742-14,969-13,040-9,746-30,396-32,258-30,748-22,823-25,762-24,051-22,614-21,411-20,617-19,291-18,164-17,021-17,507-16,231-15,320-14,687-13,786-12,568
   Accumulated Other Comprehensive Income 
-3,361
-3,338
-3,312
-70
-70
-69
-63
-195
-199
-203
-201
-340
-345
-334
-339
-391
0
0
0
-526
-631
-837
-1,067
69
73
79
78
83
1,297
1,461
1,655
1,901
1,857
1,929
2,113
-3,825
-3,926
-4,057
-4,041
-2,682
267
-525
-910
-333
-15
-293
-255
300
525
1,181
1,444
1,212
1,127
333
822
555
231
430
636
445
422
443
376
429
423
308
240
250
193
122
76
57
552
526
929
1,141
1,307
903
919
1,369
1,168
1,737
-1,028
56
-178
126
333
986
-63
-28
12
21
29
-4
-466
-481
-585
-809
-411
-44
-50
117
625
385
462
0
0
0
000462385625117-50-44-411-809-585-481-466-4292112-28-63986333126-17856-1,0281,7371,1681,3699199031,3071,14192952655257761221932502403084234293764434224456364302315558223331,1271,2121,4441,181525300-255-293-15-333-910-525267-2,682-4,041-4,057-3,926-3,8252,1131,9291,8571,9011,6551,4611,2978378797369-1,067-837-631-526000-391-339-334-345-340-201-203-199-195-63-69-70-70-3,312-3,338-3,361
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,019
9,262
9,525
10,783
11,147
11,469
11,803
12,065
12,597
12,336
12,457
12,843
14,281
15,037
17,977
18,810
19,436
20,148
22,794
0
022,79420,14819,43618,81017,97715,03714,28112,84312,45712,33612,59712,06511,80311,46911,14710,7839,5259,2629,0190000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
26,523
26,339
26,206
22,417
22,344
29,658
28,347
29,297
29,831
34,588
39,209
39,863
42,727
57,597
61,967
69,673
69,372
69,950
69,437
69,580
87,273
91,840
90,300
88,966
93,840
101,524
100,752
107,697
116,513
114,146
118,469
131,041
126,101
124,041
131,049
135,490
139,469
164,103
163,557
158,597
206,063
227,057
230,256
243,527
279,410
275,746
258,403
221,277
224,381
261,619
260,552
270,070
272,048
271,507
270,412
281,707
294,108
295,237
294,759
279,615
290,667
280,551
291,182
290,965
7,981
7,956
7,803
7,754
7,416
7,623
7,627
7,257
6,656
6,721
6,445
6,418
6,384
10,599
10,763
10,562
10,945
10,963
11,862
11,745
11,963
7,957
12,579
12,271
13,476
13,719
13,982
15,240
15,604
15,926
16,260
16,522
17,054
16,793
16,914
17,300
18,738
19,494
20,109
20,942
21,568
2,675
586
0
05862,67521,56820,94220,10919,49418,73817,30016,91416,79317,05416,52216,26015,92615,60415,24013,98213,71913,47612,27112,5797,95711,96311,74511,86210,96310,94510,56210,76310,5996,3846,4186,4456,7216,6567,2577,6277,6237,4167,7547,8037,9567,981290,965291,182280,551290,667279,615294,759295,237294,108281,707270,412271,507272,048270,070260,552261,619224,381221,277258,403275,746279,410243,527230,256227,057206,063158,597163,557164,103139,469135,490131,049124,041126,101131,041118,469114,146116,513107,697100,752101,52493,84088,96690,30091,84087,27369,58069,43769,95069,37269,67361,96757,59742,72739,86339,20934,58829,83129,29728,34729,65822,34422,41726,20626,33926,523



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-11-30)

Gross Profit (+$)
totalRevenue81,764
Cost of Revenue-19,635
Gross Profit62,12962,129
 
Operating Income (+$)
Gross Profit62,129
Operating Expense-92,391
Operating Income-10,627-30,262
 
Operating Expense (+$)
Research Development30,370
Selling General Administrative42,386
Selling And Marketing Expenses-
Operating Expense92,39172,756
 
Net Interest Income (+$)
Interest Income769
Interest Expense-10,361
Other Finance Cost-996
Net Interest Income-10,588
 
Pretax Income (+$)
Operating Income-10,627
Net Interest Income-10,588
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-23,536-8,306
EBIT - interestExpense = -10,361
-23,957
-13,596
Interest Expense10,361
Earnings Before Interest and Taxes (EBIT)--13,175
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-23,536
Tax Provision-421
Net Income From Continuing Ops-23,957-23,957
Net Income-23,957
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-2,32110,588
 

Technical Analysis of Theratech
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Theratech. The general trend of Theratech is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Theratech's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Theratechnologies Inc..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.27 < 2.4 < 3.29.

The bearish price targets are: 5.04 > 3.04 > 1.63.

Tweet this
Theratechnologies Inc. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Theratechnologies Inc.. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Theratechnologies Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Theratechnologies Inc.. The current macd is -0.03175279.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Theratech price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Theratech. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Theratech price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Theratechnologies Inc. Daily Moving Average Convergence/Divergence (MACD) ChartTheratechnologies Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Theratechnologies Inc.. The current adx is 20.29.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Theratech shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Theratechnologies Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Theratechnologies Inc.. The current sar is 2.0983261.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Theratechnologies Inc. Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Theratechnologies Inc.. The current rsi is 42.85. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Theratechnologies Inc. Daily Relative Strength Index (RSI) ChartTheratechnologies Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Theratechnologies Inc.. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Theratech price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Theratechnologies Inc. Daily Stochastic Oscillator ChartTheratechnologies Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Theratechnologies Inc.. The current cci is -81.87297172.

Theratechnologies Inc. Daily Commodity Channel Index (CCI) ChartTheratechnologies Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Theratechnologies Inc.. The current cmo is -21.06389523.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Theratechnologies Inc. Daily Chande Momentum Oscillator (CMO) ChartTheratechnologies Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Theratechnologies Inc.. The current willr is -95.45454545.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Theratechnologies Inc. Daily Williams %R ChartTheratechnologies Inc. Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Theratechnologies Inc..

Theratechnologies Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Theratechnologies Inc.. The current atr is 0.1136394.

Theratechnologies Inc. Daily Average True Range (ATR) ChartTheratechnologies Inc. Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Theratechnologies Inc.. The current obv is -988,841.

Theratechnologies Inc. Daily On-Balance Volume (OBV) ChartTheratechnologies Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Theratechnologies Inc.. The current mfi is 39.31.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Theratechnologies Inc. Daily Money Flow Index (MFI) ChartTheratechnologies Inc. Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Theratechnologies Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Theratechnologies Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Theratechnologies Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.854
Ma 20Greater thanMa 501.961
Ma 50Greater thanMa 1001.960
Ma 100Greater thanMa 2002.134
OpenGreater thanClose1.800
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Theratech with someone you think should read this too:
  • Are you bullish or bearish on Theratech? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Theratech? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Theratechnologies Inc.

I send you an email if I find something interesting about Theratechnologies Inc..


Comments

How you think about this?

Leave a comment

Stay informed about Theratechnologies Inc..

Receive notifications about Theratechnologies Inc. in your mailbox!